{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:53:42Z","timestamp":1779299622237,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The phospholipase A2 receptor (PLA2R) associated with membranous nephropathy (MN) is an organ-specific autoimmune disease associated with <jats:italic>PLA2R<\/jats:italic> and human leukocyte antigen (<jats:italic>HLA<\/jats:italic>) genes. Familial PLA2R-related MN is rarely reported. The combination of anti-GBM disease and MN has been well documented, though the mechanism behind it remains unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe two siblings diagnosed with pathology-confirmed PLA2R-related MN 1 year apart. And one of the two siblings developed an anti-GBM disease. The high-resolution HLA typing showed identical alleles in both siblings, specifically heterozygotes of DRB1*15:01\/*03:01.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We describe a familial case of PLA2R-related MN supporting the role of genetic factors that HLA-DRB1*15:01 and DRB1*03:01 predispose patients in the development of PLA2R-related MN in the Han Chinese population. The combination of MN and anti-GBM disease may also partially be associated with the same susceptible HLA allele DRB1*15:01.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03132-2","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:15:18Z","timestamp":1687425318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary membranous nephropathy in two siblings with one combined with anti-glomerular basement membrane disease: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Yan-jiao","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-ru","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-juan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-de","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"3132_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase a(sub 2) receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"3132_CR2","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH, Meyer-Schwesinger C, Seitz-Polski B, Ma H, Zahner G, et al. Thrombospondin Type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med. 2014;371:2277\u201387.","journal-title":"N Engl J Med"},{"key":"3132_CR3","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1681\/ASN.2018080852","volume":"30","author":"S Sethi","year":"2019","unstructured":"Sethi S, Madden BJ, Debiec H, Charlesworth MC, Gross L, Ravindran A, et al. Exostosin 1\/Exostosin 2-associated membranous nephropathy. J Am Soc Nephrol. 2019;30:1123\u201336.","journal-title":"J Am Soc Nephrol"},{"key":"3132_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","volume":"97","author":"S Sethi","year":"2020","unstructured":"Sethi S, Debiec H, Madden B, Charlesworth MC, Morelle J, Gross L, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2020;97:163\u201374.","journal-title":"Kidney Int"},{"key":"3132_CR5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40620-017-0451-5","volume":"31","author":"A Radice","year":"2018","unstructured":"Radice A, Pieruzzi F, Trezzi B, Ghiggeri G, Napodano P, D\u2019Amico M, et al. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. J Nephrol. 2018;31:271\u20138.","journal-title":"J Nephrol"},{"key":"3132_CR6","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ki.2013.364","volume":"85","author":"X Jia","year":"2014","unstructured":"Jia X, Hu S, Chen J, Qu Z, Liu G, Cui Z, et al. The clinical and immunological features of patients with combined anti-glomerular basement membrane disease and membranous nephropathy. Kidney Int. 2014;85:945\u201352.","journal-title":"Kidney Int"},{"key":"3132_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.ajkd.2020.11.023","volume":"78","author":"SB Ahmad","year":"2021","unstructured":"Ahmad SB, Santoriello D, Canetta P, Bomback AS, D\u2019Agati VD, Markowitz G, et al. Concurrent anti-glomerular basement membrane antibody disease and membranous nephropathy: a case series. Am J Kidney Dis. 2021;78:219\u2013225.e1.","journal-title":"Am J Kidney Dis"},{"key":"3132_CR8","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie J, Liu L, Mladkova N, Li Y, Ren H, Wang W, et al. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. Nat Commun. 2020;11:1600.","journal-title":"Nat Commun"},{"key":"3132_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1681\/ASN.2016020114","volume":"28","author":"Z Cui","year":"2017","unstructured":"Cui Z, Xie L, Chen F, Pei Z, Zhang L, Qu Z, et al. MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy. JASN. 2017;28:1651\u201364.","journal-title":"JASN."},{"key":"3132_CR10","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1681\/ASN.2016060644","volume":"28","author":"WB Le","year":"2017","unstructured":"Le WB, Shi JS, Zhang T, Liu L, Qin HZ, Liang S, et al. HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-related membranous nephropathy. J Am Soc Nephrol. 2017;28:1642\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"3132_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/imm.12736","volume":"151","author":"L-J Xie","year":"2017","unstructured":"Xie L-J, Cui Z, Chen F-J, Pei Z-Y, Hu S-Y, Gu Q-H, et al. The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture\u2019s disease. Immunology. 2017;151:395\u2013404.","journal-title":"Immunology."},{"key":"3132_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","volume":"364","author":"HC Stanescu","year":"2011","unstructured":"Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364:616\u201326.","journal-title":"N Engl J Med"},{"key":"3132_CR13","first-page":"193","volume":"5","author":"D Vasmant","year":"1984","unstructured":"Vasmant D, Murnaghan K, Bensman A, Muller JY, Mougenot B. Familial idiopathic membranous glomerulonephritis. Int J Pediatr Nephrol. 1984;5:193\u20136.","journal-title":"Int J Pediatr Nephrol"},{"key":"3132_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000185130","volume":"50","author":"A Vangelista","year":"1988","unstructured":"Vangelista A, Tazzari R, Bonomini V. Idiopathic membranous nephropathy in 2 twin brothers. Nephron. 1988;50:79\u201380.","journal-title":"Nephron."},{"key":"3132_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000186444","volume":"58","author":"S Mezzano","year":"1991","unstructured":"Mezzano S, Rojas G, Ardiles L, Caorsi I, Bertoglio JC, Lopez MI, et al. Idiopathic membranous nephropathy, associated with HLA-DRw3 and not related to monocyte-phagocyte system fc receptor dysfunction, in father and son. Nephron. 1991;58:320\u20134.","journal-title":"Nephron."},{"key":"3132_CR16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ndt\/10.supp6.108","volume":"10","author":"M Maccario","year":"1995","unstructured":"Maccario M, Segagni S, Efficace E, Piazza V, Poggio F, Villa G, et al. Idiopathic membranous nephropathy in two siblings. Nephrol Dial Transplant. 1995;10:108\u201310.","journal-title":"Nephrol Dial Transplant"},{"key":"3132_CR17","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s40620-020-00770-9","volume":"34","author":"T Tao","year":"2021","unstructured":"Tao T, Wang J, Lei S, Hu Z. Identical twins with idiopathic membranous nephropathy. J Nephrol. 2021;34:597\u2013601.","journal-title":"J Nephrol."},{"key":"3132_CR18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2018.06.005","volume":"94","author":"H Wang","year":"2018","unstructured":"Wang H, Cui Z, Xie L, Zhang L, Pei Z-Y, Chen F, et al. HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy. Kidney Int. 2018;94:974\u201382.","journal-title":"Kidney Int"},{"key":"3132_CR19","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ekir.2019.07.021","volume":"4","author":"A Nikolopoulou","year":"2019","unstructured":"Nikolopoulou A, Huang-Doran I, McAdoo SP, Griffith ME, Cook HT, Pusey CD. Membranous glomerulonephritis with crescents. Kidney International Reports. 2019;4:1577\u201384.","journal-title":"Kidney International Reports"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03132-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03132-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T09:17:43Z","timestamp":1687425463000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03132-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3132"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03132-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]},"assertion":[{"value":"30 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the Declaration of Helsinki and was approved by the ethics committee of Peking University First Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from both patients for their personal or clinical details along with any identifying images to be published in this study. Copies of the written consent are available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}